Impedance Pneumography in Assessment of Asthma Control in Preschool Children (IPAAC)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03377192 |
|
Recruitment Status : Unknown
Verified February 2020 by Pekka Malmberg, MD, PhD, HUS Skin and Allergy Hospital.
Recruitment status was: Active, not recruiting
First Posted : December 19, 2017
Last Update Posted : February 13, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Wheezing Asthma in Children |
Lung function assessment of preschool children is hindered by their limited co-operation in conventional tests such as peak expiratory flow (PEF) or spirometry. However, indices derived from spontaneous tidal respiratory air flow and the shape of tidal expiratory flow-volume and flow-time curves relate to lung function and are easier to record even in young children. As a more advanced approach, the time dynamics and complexity properties of the tidal breathing flow volume (TBFV) signal have been analysed and found to relate to various respiratory conditions.
Impedance pneumography (IP) is a method for measuring changes in the thoracic electrical impedance through skin electrodes, which varies as a function of lung aeration i.e. breathing. Recent technical advancements have enabled IP to be used for accurate non-invasive tidal flow signal measurement. Moreover, in overnight recordings at home, IP was found feasible for quantifying nocturnal TBFV variability in young children with lower respiratory symptoms, showing that preschool children with high risk of asthma present with increased variation of tidal flow profile shape, and momentarily lowered chaoticity, compared to children with lower risk of asthma. So far, there are no studies that have addressed the utility of IP to assess asthma control in young children with asthma.
The purpose of this study is to investigate the utility of a commercially available IP device (VENTICA, Icare Finland, Finland) and IP-derived clinical indices in assessing the clinical control of asthmatic children receiving normal therapy in a longitudinal setting. The primary hypothesis is that TBFV variability quantified by IP is associated with disease control during management of young children with asthma. The secondary hypothesis is that TBFV variability quantified by IP predicts changes in disease control during management of young children with asthma.
| Study Type : | Observational |
| Actual Enrollment : | 53 participants |
| Observational Model: | Case-Only |
| Time Perspective: | Prospective |
| Official Title: | Impedance Pneumography in Assessment of Asthma Control in Preschool Children |
| Actual Study Start Date : | November 28, 2017 |
| Actual Primary Completion Date : | November 14, 2019 |
| Estimated Study Completion Date : | June 2020 |
- Childhood asthma control test (C-ACT) [ Time Frame: Weekly up to maximum 6 months or until loss of asthma control/exacerbation ]Questionnaire that measures current asthma control, including 7 questions and a minimum score of 0 and maximum score of 27; score 19 or less indicates that asthma is not controlled.
- Time-to-response (TTR) [ Time Frame: Minimum of 30 days from initiation of anti-asthmatic medication up to max 6 months ]Duration from visit 1 to good asthma control (C-ACT>19)
- Time-to-loss-of-control (TTLOC) [ Time Frame: Minimum of 30 days from initiation of anti-asthmatic medication up to max 6 months ]Duration from the visit 2 and 3 until loss of asthma control (C-ACT<16) or asthma exacerbation
- Lung function [ Time Frame: Every visit up to maximum 6 months ]Respiratory resistance and exercise induced increase in resistance, measured by the oscillometric method
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 4 Years to 7 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Age 4-7 years, both sexes
- Attending pediatric ward in the study centre due to asthmatic symptoms (wheeze, cough and/or dyspnea)
- History and clinical signs allowing diagnosis of doctor diagnosed asthma and the need to start regular anti-asthmatic medication
- Signed informed consent
Exclusion Criteria:
- Use of inhaled corticosteroid medication 30 days prior to study entry
- Other cardiorespiratory or neurological chronic diseases or states that may affect breathing
- Acute respiratory infection 2 weeks prior to study entry
- Chronic respiratory disorder of prematurity
- Implanted or external active medical devices
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03377192
| Finland | |
| HUS Skin and Allergy Hospital | |
| Helsinki, Finland, 00029 | |
| Mehiläinen Paediatric Allergy Clinic | |
| Helsinki, Finland, 00260 | |
| Principal Investigator: | Pekka Malmberg, MD, PhD | HUS Skin and Allergy Hospital |
| Responsible Party: | Pekka Malmberg, MD, PhD, Head of clinical physiology, HUS Skin and Allergy Hospital |
| ClinicalTrials.gov Identifier: | NCT03377192 |
| Other Study ID Numbers: |
VCS-002 |
| First Posted: | December 19, 2017 Key Record Dates |
| Last Update Posted: | February 13, 2020 |
| Last Verified: | February 2020 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Impedance pneumography Respiratory function Asthma management |
|
Asthma Respiratory Sounds Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases Signs and Symptoms, Respiratory |